M. Jonathan Fray
Department of Discovery Chemistry
Pfizer Global Research and Development
Sandwich
UK
Name/email consistency: high
- A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers. Fray, M.J., Dickinson, R.P., Huggins, J.P., Occleston, N.L. J. Med. Chem. (2003)
- Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality. Fray, M.J., Burslem, M.F., Dickinson, R.P. Bioorg. Med. Chem. Lett. (2001)
- Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1). Fray, M.J., Dickinson, R.P. Bioorg. Med. Chem. Lett. (2001)